Entry - #619185 - JOUBERT SYNDROME 37; JBTS37 - OMIM
# 619185

JOUBERT SYNDROME 37; JBTS37


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q21.2 Joubert syndrome 37 619185 AR 3 TOGARAM1 617618
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Height
- Short stature
HEAD & NECK
Face
- Dysmorphic facial features
- Frontal bossing
- Metopic ridge
- Microcephaly (in some patients)
Ears
- Low-set ears
- Posteriorly rotated ears
Eyes
- Deep-set eyes
- Hypertelorism
- Oculomotor apraxia
- Abnormal eye movements
- Strabismus
- Ptosis
- Coloboma
- Microphthalmia
Nose
- Broad nasal bridge
- Broad nose
- Anteverted alae
Mouth
- High-arched palate
- Cleft lip
- Cleft palate
RESPIRATORY
- Apnea (in some patients)
CHEST
Breasts
- Widely spaced nipples
ABDOMEN
Liver
- Hepatomegaly
- Cholestasis
GENITOURINARY
External Genitalia (Male)
- Small scrotum
- Micropenis
- Cryptorchidism
Kidneys
- Hydronephrosis (in some patients)
- Small kidney (in some patients)
SKELETAL
Spine
- Hyperlordosis
Limbs
- Joint hypermobility
Hands
- Postaxial polydactyly
Feet
- Postaxial polydactyly
NEUROLOGIC
Central Nervous System
- Global developmental delay
- Impaired intellectual development
- Poor or absent language
- Hypotonia
- Ataxia
- Hydrocephalus
- Lissencephaly (in some patients)
- Molar tooth sign seen on brain imaging
- Cerebellar vermis hypoplasia
- Horizontally oriented superior cerebellar peduncles
- Corpus callosum hypoplasia
Behavioral Psychiatric Manifestations
- Behavioral problems
MISCELLANEOUS
- Onset in utero
- Death in utero (in some patients)
- Variable features
- Variable severity
MOLECULAR BASIS
- Caused by mutation in the TOG array regulator of axonemal microtubules 1 (TOGARAM1, 617618.0001)
Joubert syndrome - PS213300 - 43 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32 Joubert syndrome 25 AR 3 616781 CEP104 616690
2q13 Joubert syndrome 4 AR 3 609583 NPHP1 607100
2q33.1 Joubert syndrome 14 AR 3 614424 TMEM237 614423
2q37.1 Joubert syndrome 30 AR 3 617622 ARMC9 617612
2q37.1 Joubert syndrome 22 AR 3 615665 PDE6D 602676
3q11.1-q11.2 Joubert syndrome 8 AR 3 612291 ARL13B 608922
4p15.32 Joubert syndrome 9 AR 3 612285 CC2D2A 612013
5p13.2 Joubert syndrome 17 AR 3 614615 CPLANE1 614571
5q23.2 Joubert syndrome 31 AR 3 617761 CEP120 613446
6q23.3 Joubert syndrome 3 AR 3 608629 AHI1 608894
7q32.2 Joubert syndrome 15 AR 3 614464 CEP41 610523
8q13.1-q13.2 Joubert syndrome 21 AR 3 615636 CSPP1 611654
8q22.1 Joubert syndrome 6 AR 3 610688 TMEM67 609884
9p21.2 Joubert syndrome 40 AR 3 619582 IFT74 608040
9q34.3 Joubert syndrome 1 AR 3 213300 INPP5E 613037
10q22.2 Joubert syndrome 36 AR 3 618763 FAM149B1 618413
10q24.1 Joubert syndrome 18 AR 3 614815 TCTN3 613847
10q24.32 Joubert syndrome 32 AR 3 617757 SUFU 607035
10q24.32 Joubert syndrome 35 AR 3 618161 ARL3 604695
11q12.2 Joubert syndrome 16 AR 3 614465 TMEM138 614459
11q12.2 Joubert syndrome 2 AR 3 608091 TMEM216 613277
11q24.2 Joubert syndrome 39 AR 3 619562 TMEM218 619285
12q21.32 Joubert syndrome 5 AR 3 610188 CEP290 610142
12q24.11 Joubert syndrome 13 AR 3 614173 TECT1 609863
12q24.31 Joubert syndrome 24 AR 3 616654 TCTN2 613846
13q21.33-q22.1 Joubert syndrome 33 AR 3 617767 PIBF1 607532
14q21.2 Joubert syndrome 37 AR 3 619185 TOGARAM1 617618
14q23.1 Joubert syndrome 23 AR 3 616490 KIAA0586 610178
15q26.1 Joubert syndrome 12 AR 3 200990 KIF7 611254
15q26.1 Acrocallosal syndrome AR 3 200990 KIF7 611254
16p12.1 Joubert syndrome 26 AR 3 616784 KATNIP 616650
16q12.1 Joubert syndrome 19 AD, AR 3 614844 ZNF423 604557
16q12.1 Nephronophthisis 14 AD, AR 3 614844 ZNF423 604557
16q12.2 Joubert syndrome 7 AR 3 611560 RPGRIP1L 610937
16q23.1 Joubert syndrome 20 AR 3 614970 TMEM231 614949
17p13.1 ?Joubert syndrome 38 AR 3 619476 KIAA0753 617112
17p13.1 ?Joubert syndrome 29 AR 3 617562 TMEM107 616183
17p13.1 Meckel syndrome 13 AR 3 617562 TMEM107 616183
17p11.2 Joubert syndrome 27 AR 3 617120 B9D1 614144
17q22 Joubert syndrome 28 AR 3 617121 MKS1 609883
19q13.2 Joubert syndrome 34 AR 3 614175 B9D2 611951
19q13.2 ?Meckel syndrome 10 AR 3 614175 B9D2 611951
Xp22.2 Joubert syndrome 10 XLR 3 300804 OFD1 300170

TEXT

A number sign (#) is used with this entry because of evidence that Joubert syndrome-37 (JBTS37) is caused by homozygous or compound heterozygous mutation in the TOGARAM1 gene (617618) on chromosome 14q21.


Description

Joubert syndrome-37 (JBTS37) is an autosomal recessive neurodevelopmental ciliopathy characterized classically by a distinctive hindbrain malformation affecting the midbrain and cerebellum, recognizable as the 'molar tooth sign' on brain imaging. Affected individuals have hypotonia, ataxia, and variably impaired intellectual development. Additional variable features, such as postaxial polydactyly, liver or kidney anomalies, retinal dystrophy, and coloboma, may also occur. In severe cases, affected fetuses with these malformations may be terminated (summary by Latour et al., 2020).

For a phenotypic description and a discussion of genetic heterogeneity of Joubert syndrome, see JBTS1 (213300).


Clinical Features

Latour et al. (2020) reported 5 unrelated patients, including a fetus, with clinical features consistent with Joubert syndrome, including neurodevelopmental delay and classic brain imaging findings of absent cerebellar vermis and thick, horizontally oriented superior cerebellar peduncles, giving the appearance of the molar tooth sign. The fetus had cerebellar vermis hypoplasia, postaxial foot polydactyly, and abnormal craniofacial features, such as broad nasal bridge and posteriorly rotated ears. The living children, who ranged from 6 to 16 years of age, had hypotonia, ataxia, cognitive impairment, poor or absent speech, and behavioral abnormalities. More variable features included abnormal eye movements, apnea, kidney and liver involvement, and postaxial polydactyly. One patient (WGL-1914) had hydronephrosis, hepatomegaly, cholestasis, microphthalmia, and coloboma, and another (JAS-L50) had a small scarred left kidney and short stature. Dysmorphic features included broad nasal bridge or nose with anteverted alae, deep-set eyes, hypertelorism, metopic ridge, frontal bossing, low-set ears, ptosis, high-arched palate, widely-spaced nipples, small scrotum, micropenis, undescended testes, hyperlordosis, and joint hypermobility. The patients were ascertained from several large cohorts of patients with clinical features of JBTS, a ciliopathy, or neurodevelopmental disorders who underwent exome or genome sequencing.

Morbidoni et al. (2021) reported a family in which 2 male fetuses, born of unrelated parents, were terminated in the second trimester due to multiple fetal abnormalities. The fetuses had microcephaly, microphthalmia, cleft lip and palate, and brain malformations. Both had hydrocephalus, 1 had cerebellar hypoplasia, and the other had lissencephaly. The heart and skeletal systems were normal; renal and hepatic features were not mentioned. The authors noted phenotypic overlap with Meckel-Gruber syndrome (see MKS1, 249000).


Inheritance

The transmission pattern of JBTS37 in the families reported by Latour et al. (2020) was consistent with autosomal recessive inheritance.


Molecular Genetics

In 5 unrelated patients, including a fetus, with JBTS37, Latour et al. (2020) identified homozygous or compound heterozygous mutations in the TOGARAM1 gene (see, e.g., 617618.0001-617618.0006). The mutations, which were found by exome sequencing of several large cohorts of patients with JBTS, segregated with the disorder in the families and were either very rare or not present in the gnomAD database. There were missense and nonsense mutations, as well as an intragenic deletion, and most mutations affected the TOG2 and TOG3 functional domains of the protein. In vitro functional cellular expression studies of some of the variants in TOGARAM1-null retinal pigment epithelial (RPE) cells showed that those affecting the TOG2 domain (R368W, 617618.0005 and L375P, 617618.0001), which promotes microtubule polymerization, resulted in longer cilia compared to controls, whereas a mutation affecting the TOG3 domain (R1311C; 617618.0002) resulted in shortened cilia. Variants in the TOG2 domain abolished the interaction between TOGARAM1 and ARMC9 (617612), whereas the TOG3 mutation did not influence this interaction. Fibroblasts, available from 1 patient (UW360-3) only, showed slightly shorter cilia length compared to controls (2.6 versus 3.0 micrometers) and a slightly lower ciliation rate compared to controls (85% versus 91%). Further detailed studies of patient fibroblasts and ciliated cells from mutant zebrafish showed reduced acetylation and polyglutamylation of axonemal microtubules compared to controls, indicating impaired posttranslational modification of tubulin, as well as abnormal ciliary stability. There was also evidence of impaired SHH (600725)/ SMO (601500) signaling. The transition zone (TZ), which connects the axoneme to the ciliary membrane, was unaffected. Latour et al. (2020) initially used ARMC9 as a bait to identify interacting proteins, which yielded TOGARAM1 as a candidate gene for Joubert syndrome. The findings characterized a novel ARMC9/TOGARAM1 protein module that plays an important role in ciliary stability and function.

In 2 male fetuses, born of unrelated parents, with a severe form of JBTS37, Morbidoni et al. (2021) identified compound heterozygous mutations in the TOGARAM1 gene (R368W, 617618.0005 and R1207X, 617618.0007). The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, were each inherited from an unaffected parent. Morbidoni et al. (2021) noted that knockdown of the C. elegans orthologous TOGARAM1 gene (che12) results in ciliary defects. Che12 is expressed in ciliated dendritic sensory neurons. Generation of mutant C. elegans harboring a R284W mutation (equivalent to the human R368W mutation) demonstrated normal chemotaxis, but had defective uptake of lipophilic dye compared to controls. This was associated with shortened cilium length and disorganized ciliary architecture. Expression of the corresponding mouse mutation (R367W) in E. coli resulted in increased tubulin polymerization, suggesting altered tubulin-binding activity of mutant Togaram1. These findings were consistent with a hypomorphic effect of the missense variant.


Animal Model

Using Cas9-triggered homologous recombination, Das et al. (2015) generated a C. elegans mutant with a deletion of the coding sequence of Che12, the C. elegans Crescerin-1 ortholog. C. elegans with the Che12 deletion displayed dramatically shorter cilia compared with wildtype. Cilia of Che12 deletion mutants also exhibited ultrastructural defects, including poorly defined microtubule architecture, and they were unable to sense and respond to a sodium chloride gradient in chemotaxis assays. In strains with targeted mutations of Che12 TOG domains, mutant Che12 properly localized to cilia, but the mutants otherwise phenocopied the Che12 deletion strain. Das et al. (2015) concluded that the TOG domain tubulin-binding activity of Che12 is required for proper sensory cilia development and cilia-based chemotactic function in C. elegans.

Latour et al. (2020) found that knockdown of the togaram1 ortholog in zebrafish resulted in increased frequency of ciliary defects, including curved body shape with scoliosis and development of kidney cysts. The phenotype resembled that of zebrafish with mutant armc9 (617612). Both mutant animals had reduced numbers of shortened pronephric, ventricular, and nose pit cilia.


REFERENCES

  1. Das, A., Dickinson, D. J., Wood, C. C., Goldstein, B., Slep, K. C. Crescerin uses a TOG domain array to regulate microtubules in the primary cilium. Molec. Biol. Cell 26: 4248-4264, 2015. [PubMed: 26378256, related citations] [Full Text]

  2. Latour, B. L., Van De Weghe, J. C., Rusterholz, T. D. S., Letteboer, S. J. F., Gomez, A., Shaheen, R., Gesemann, M., Karamzade, A., Asadollahi, M., Barroso-Gil, M., Chitre, M., Grout, M. E., and 18 others. Dysfunction of the ciliary ARMC9/TOGARAM1 protein module causes Joubert syndrome. J. Clin. Invest. 130: 4423-4439, 2020. [PubMed: 32453716, related citations] [Full Text]

  3. Morbidoni, V., Agolini, E., Slep, K. C., Pannone, L., Zuccarello, D., Cassina, M., Grosso, E., Gai, G., Salviati, L., Dallapiccola, B., Novelli, A., Martinelli, S., Trevisson, E. Biallelic mutations in the TOGARAM1 gene cause a novel primary ciliopathy. J. Med. Genet. 58: 526-533, 2021. [PubMed: 32747439, related citations] [Full Text]


Creation Date:
Cassandra L. Kniffin : 02/15/2021
carol : 08/13/2021
alopez : 02/22/2021
ckniffin : 02/16/2021

# 619185

JOUBERT SYNDROME 37; JBTS37


ORPHA: 475;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q21.2 Joubert syndrome 37 619185 Autosomal recessive 3 TOGARAM1 617618

TEXT

A number sign (#) is used with this entry because of evidence that Joubert syndrome-37 (JBTS37) is caused by homozygous or compound heterozygous mutation in the TOGARAM1 gene (617618) on chromosome 14q21.


Description

Joubert syndrome-37 (JBTS37) is an autosomal recessive neurodevelopmental ciliopathy characterized classically by a distinctive hindbrain malformation affecting the midbrain and cerebellum, recognizable as the 'molar tooth sign' on brain imaging. Affected individuals have hypotonia, ataxia, and variably impaired intellectual development. Additional variable features, such as postaxial polydactyly, liver or kidney anomalies, retinal dystrophy, and coloboma, may also occur. In severe cases, affected fetuses with these malformations may be terminated (summary by Latour et al., 2020).

For a phenotypic description and a discussion of genetic heterogeneity of Joubert syndrome, see JBTS1 (213300).


Clinical Features

Latour et al. (2020) reported 5 unrelated patients, including a fetus, with clinical features consistent with Joubert syndrome, including neurodevelopmental delay and classic brain imaging findings of absent cerebellar vermis and thick, horizontally oriented superior cerebellar peduncles, giving the appearance of the molar tooth sign. The fetus had cerebellar vermis hypoplasia, postaxial foot polydactyly, and abnormal craniofacial features, such as broad nasal bridge and posteriorly rotated ears. The living children, who ranged from 6 to 16 years of age, had hypotonia, ataxia, cognitive impairment, poor or absent speech, and behavioral abnormalities. More variable features included abnormal eye movements, apnea, kidney and liver involvement, and postaxial polydactyly. One patient (WGL-1914) had hydronephrosis, hepatomegaly, cholestasis, microphthalmia, and coloboma, and another (JAS-L50) had a small scarred left kidney and short stature. Dysmorphic features included broad nasal bridge or nose with anteverted alae, deep-set eyes, hypertelorism, metopic ridge, frontal bossing, low-set ears, ptosis, high-arched palate, widely-spaced nipples, small scrotum, micropenis, undescended testes, hyperlordosis, and joint hypermobility. The patients were ascertained from several large cohorts of patients with clinical features of JBTS, a ciliopathy, or neurodevelopmental disorders who underwent exome or genome sequencing.

Morbidoni et al. (2021) reported a family in which 2 male fetuses, born of unrelated parents, were terminated in the second trimester due to multiple fetal abnormalities. The fetuses had microcephaly, microphthalmia, cleft lip and palate, and brain malformations. Both had hydrocephalus, 1 had cerebellar hypoplasia, and the other had lissencephaly. The heart and skeletal systems were normal; renal and hepatic features were not mentioned. The authors noted phenotypic overlap with Meckel-Gruber syndrome (see MKS1, 249000).


Inheritance

The transmission pattern of JBTS37 in the families reported by Latour et al. (2020) was consistent with autosomal recessive inheritance.


Molecular Genetics

In 5 unrelated patients, including a fetus, with JBTS37, Latour et al. (2020) identified homozygous or compound heterozygous mutations in the TOGARAM1 gene (see, e.g., 617618.0001-617618.0006). The mutations, which were found by exome sequencing of several large cohorts of patients with JBTS, segregated with the disorder in the families and were either very rare or not present in the gnomAD database. There were missense and nonsense mutations, as well as an intragenic deletion, and most mutations affected the TOG2 and TOG3 functional domains of the protein. In vitro functional cellular expression studies of some of the variants in TOGARAM1-null retinal pigment epithelial (RPE) cells showed that those affecting the TOG2 domain (R368W, 617618.0005 and L375P, 617618.0001), which promotes microtubule polymerization, resulted in longer cilia compared to controls, whereas a mutation affecting the TOG3 domain (R1311C; 617618.0002) resulted in shortened cilia. Variants in the TOG2 domain abolished the interaction between TOGARAM1 and ARMC9 (617612), whereas the TOG3 mutation did not influence this interaction. Fibroblasts, available from 1 patient (UW360-3) only, showed slightly shorter cilia length compared to controls (2.6 versus 3.0 micrometers) and a slightly lower ciliation rate compared to controls (85% versus 91%). Further detailed studies of patient fibroblasts and ciliated cells from mutant zebrafish showed reduced acetylation and polyglutamylation of axonemal microtubules compared to controls, indicating impaired posttranslational modification of tubulin, as well as abnormal ciliary stability. There was also evidence of impaired SHH (600725)/ SMO (601500) signaling. The transition zone (TZ), which connects the axoneme to the ciliary membrane, was unaffected. Latour et al. (2020) initially used ARMC9 as a bait to identify interacting proteins, which yielded TOGARAM1 as a candidate gene for Joubert syndrome. The findings characterized a novel ARMC9/TOGARAM1 protein module that plays an important role in ciliary stability and function.

In 2 male fetuses, born of unrelated parents, with a severe form of JBTS37, Morbidoni et al. (2021) identified compound heterozygous mutations in the TOGARAM1 gene (R368W, 617618.0005 and R1207X, 617618.0007). The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, were each inherited from an unaffected parent. Morbidoni et al. (2021) noted that knockdown of the C. elegans orthologous TOGARAM1 gene (che12) results in ciliary defects. Che12 is expressed in ciliated dendritic sensory neurons. Generation of mutant C. elegans harboring a R284W mutation (equivalent to the human R368W mutation) demonstrated normal chemotaxis, but had defective uptake of lipophilic dye compared to controls. This was associated with shortened cilium length and disorganized ciliary architecture. Expression of the corresponding mouse mutation (R367W) in E. coli resulted in increased tubulin polymerization, suggesting altered tubulin-binding activity of mutant Togaram1. These findings were consistent with a hypomorphic effect of the missense variant.


Animal Model

Using Cas9-triggered homologous recombination, Das et al. (2015) generated a C. elegans mutant with a deletion of the coding sequence of Che12, the C. elegans Crescerin-1 ortholog. C. elegans with the Che12 deletion displayed dramatically shorter cilia compared with wildtype. Cilia of Che12 deletion mutants also exhibited ultrastructural defects, including poorly defined microtubule architecture, and they were unable to sense and respond to a sodium chloride gradient in chemotaxis assays. In strains with targeted mutations of Che12 TOG domains, mutant Che12 properly localized to cilia, but the mutants otherwise phenocopied the Che12 deletion strain. Das et al. (2015) concluded that the TOG domain tubulin-binding activity of Che12 is required for proper sensory cilia development and cilia-based chemotactic function in C. elegans.

Latour et al. (2020) found that knockdown of the togaram1 ortholog in zebrafish resulted in increased frequency of ciliary defects, including curved body shape with scoliosis and development of kidney cysts. The phenotype resembled that of zebrafish with mutant armc9 (617612). Both mutant animals had reduced numbers of shortened pronephric, ventricular, and nose pit cilia.


REFERENCES

  1. Das, A., Dickinson, D. J., Wood, C. C., Goldstein, B., Slep, K. C. Crescerin uses a TOG domain array to regulate microtubules in the primary cilium. Molec. Biol. Cell 26: 4248-4264, 2015. [PubMed: 26378256] [Full Text: https://doi.org/10.1091/mbc.E15-08-0603]

  2. Latour, B. L., Van De Weghe, J. C., Rusterholz, T. D. S., Letteboer, S. J. F., Gomez, A., Shaheen, R., Gesemann, M., Karamzade, A., Asadollahi, M., Barroso-Gil, M., Chitre, M., Grout, M. E., and 18 others. Dysfunction of the ciliary ARMC9/TOGARAM1 protein module causes Joubert syndrome. J. Clin. Invest. 130: 4423-4439, 2020. [PubMed: 32453716] [Full Text: https://doi.org/10.1172/JCI131656]

  3. Morbidoni, V., Agolini, E., Slep, K. C., Pannone, L., Zuccarello, D., Cassina, M., Grosso, E., Gai, G., Salviati, L., Dallapiccola, B., Novelli, A., Martinelli, S., Trevisson, E. Biallelic mutations in the TOGARAM1 gene cause a novel primary ciliopathy. J. Med. Genet. 58: 526-533, 2021. [PubMed: 32747439] [Full Text: https://doi.org/10.1136/jmedgenet-2020-106833]


Creation Date:
Cassandra L. Kniffin : 02/15/2021

Edit History:
carol : 08/13/2021
alopez : 02/22/2021
ckniffin : 02/16/2021